8194460 Is SEEL stock a good buy? [Solved]

Is SEEL stock a good buy?

Is SEEL stock a good buy?

Out of 3 analysts, 3 (100%) are recommending SEEL as a Strong Buy, 0 (0%) are recommending SEEL as a Buy, 0 (0%) are recommending SEEL as a Hold, 0 (0%) are recommending SEEL as a Sell, and 0 (0%) are recommending SEEL as a Strong Sell.

Similarly, What is the forecast for SEEL stock?

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Seelos Therapeutics Inc have a median target of 4.00, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +402.70% increase from the last price of 0.80.

Why is SEEL stock rising? What happened. Shares of Seelos Therapeutics ( SEEL 5.23% ) were skyrocketing 35.2% higher as of 11:01 a.m. EST on Friday. The huge gain came after BTIG initiated coverage on the stock with a buy recommendation and a one-year price target nearly 4.7 times higher than Seelos’ closing price on Thursday.

Thereof, When did SEEL go public?

Seelos Therapeutics Announces Pricing Of $31.25 Million Public Offering Of Common Stock. Jan 26 (Reuters) – Seelos Therapeutics Inc <SEEL.

Is SEEL undervalued?

The last rating was given by B. Riley Securities on Mar 14, 2022. The price target was changed from 0.85 to 7.61.

Predicted Opening Price for Seelos Therapeutics Inc. of Tuesday, April 12, 2022.

Fair opening price April 12, 2022 Current price
$0.81 $0.80 (Undervalued)

Is Seelos Therapeutics a good investment?

Seelos Therapeutics has received a consensus rating of Buy.

What does Seelos therapeutics do?

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of products that address unmet needs in central nervous system (CNS) disorders and other rare disorders.

What happened to Apricus Biosciences?

Apricus Biosciences Inc. completed the company’s merger with private biotechnology company Seelos Therapeutics Inc.

Where is Seelos Therapeutics located?

The Company’s portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases. Seelos is based in New York, New York.

Join TheMoney.co community and don’t forget to share this post !

Quitter la version mobile